Abiomed (ABMD) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 18.05M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q3 EPS of $0.23, $0.08 better than the analyst estimate of $0.15. Revenue for the quarter came in at $85.8 million versus the consensus estimate of $80.04 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
